Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 4/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | MME | P08473 | 2/20 | 0.49 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CCKBR | P32239 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159886 | 1.00 | NAALAD2 (0.59) | NAALAD2SLC7A5ACEFOLH1CA1 | |
| Glutamic Acid SCHEMBL4396913 | 0.96 | NAALAD2 (0.66) | NAALAD2SLC7A5ACEFOLH1CA1 | |
| D-Glutamate SCHEMBL4396908 | 0.96 | NAALAD2 (0.66) | NAALAD2SLC7A5ACEFOLH1CA1 | |
| SCHEMBL15345875 | 0.92 | FOLH1 (0.67) | NAALAD2SLC7A5ACEFOLH1MME | |
| SCHEMBL18222588 | 0.89 | ACE (0.58) | NAALAD2SLC7A5ACEMME | |
| SCHEMBL161658 | 0.89 | ACE (0.58) | NAALAD2SLC7A5ACEMME | |
| SCHEMBL9628000 | 0.89 | ACE (0.58) | NAALAD2SLC7A5ACEMME | |
| SCHEMBL161657 | 0.89 | ACE (0.58) | NAALAD2SLC7A5ACEMME | |
| SCHEMBL25409107 | 0.89 | NAALAD2 (0.57) | NAALAD2ACEMME | |
| SCHEMBL21341835 | 0.88 | NOD1 (0.50) | NAALAD2SLC7A5ACEFOLH1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250270602-A1 | STRAIN OF MICROORGANISMS AND PROCESS FOR THE FERMENTATIVE PRODUCTION OF GAMMA-GLUTAMYLTYROSINE AND GAMMA-GLUTAMYLPHENYLALANINE | WACKER CHEMIE AG (DE) | 2025-08-28 | — | — | US | claimed |
| US-12292445-B2 | Methods of selecting subjects for treatment with metabolomic modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-06 | — | — | US | claimed |
| EP-3969903-B1 | METHOD OF SELECTING SKIN TREATMENT REGIMENS, INGREDIENTS AND COMPOSITIONS | JOHNSON & JOHNSON CONSUMER INC (US) | 2024-10-09 | — | — | EP | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-11892458-B2 | Biochemical predictors of red blood cell quality | BLOODWORKS NW (US) | 2024-02-06 | — | — | US | claimed |
| US-20230410977-A1 | METHODS AND MATERIALS FOR ASSESSING RADIATION EXPOSURE | NUTECH VENTURES | 2023-12-21 | — | — | US | claimed |
| WO-2023233945-A1 | BILIARY TRACT CANCER TESTING METHOD | 株式会社日立ハイテク | 2023-12-07 | — | — | WO | claimed |
| US-11806315-B2 | Compositions and methods for small canines | Société des Produits Nestlé S.A. (CH) | 2023-11-07 | — | — | US | claimed |
| CN-115844950-B | Preparation method of kuh-seng seed extract and effective part and application of kuh-seng seed extract and effective part in preventing and treating depression | 中国中医科学院中药研究所 | 2023-10-31 | — | — | CN | claimed |
| CN-114264737-B | Separation method of water-soluble compounds in kuh-seng | 中国中医科学院中药研究所 | 2023-04-28 | — | — | CN | claimed |
| EP-2813580-A1 | Biomarkers related to metabolic age and methods using the same | Metabolon, Inc. (US) | 2014-12-17 | — | — | EP | claimed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| EP-2657705-A2 | Biomarkers for prostate cancer and methods using the same | Metabolon Inc. (US) | 2013-10-30 | — | — | EP | claimed |
| WO-2013133714-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLAND BRANDS B.V. (NL) | 2013-09-12 | — | — | WO | claimed |
| WO-2013133715-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLAND BRANDS B.V. (NL) | 2013-09-12 | — | — | WO | claimed |
| US-20130224855-A1 | CULTURE MEDIUM FOR EUKARYOTIC CELLS | FRIESLANDCAMPINA NEDERLAND HOLDING B.V. (NL) | 2013-08-29 | — | — | US | claimed |
| EP-2227689-B1 | BIOMARKERS FOR FATTY LIVER DISEASE AND METHODS USING THE SAME | METABOLON INC (US) | 2012-12-26 | — | — | EP | claimed |
| EP-0608217-A1 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1994-08-03 | — | — | EP | claimed |
| EP-0608217-A4 | SOLUBLE AND STABLE SOURCES OF TYROSINE, CYSTEINE AND GLUTAMINE FOR TOTAL PARENTERAL NUTRITION. | RES CORP TECHNOLOGIES INC (US) | 1993-12-06 | — | — | EP | claimed |
| US-5206220-A | Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-04-27 | — | — | US | claimed |